Therefore, this evidence suggested that orexin-A treatment may activate theAkt/mTOR pathway to inhibit apoptosis through regulating Bcl-2/caspase-9/c-myc expression and promote cell proliferation in pancreatic cancer cells. This evidence concerns the gene BCL2 and pancreatic neoplasm.